SCARA5 and depressive symptom measurement: The association of SCARA5 in psychiatric patients with suicide attempt had not been reported before; nevertheless, previous evidence of association with psychiatric disorders has been found in GWAS and schizophrenia and depression, among others (Carboni et al., 2018; Rincon‐Cortes et al., 2015; Xu et al., 2013).